Toriihara A - Search Results

1

Eligibility for bevacizumab as an independent prognostic factor for patients with advanced non-squamous non-small cell lung cancer: a retrospective cohort study.

Takagi Y, Toriihara A, Nakahara Y, Yomota M, Okuma Y, Hosomi Y, Shibuya M, Okamura T. Takagi Y, et al. Among authors: toriihara a. PLoS One. 2013;8(3):e59700. doi: 10.1371/journal.pone.0059700. Epub 2013 Mar 26. PLoS One. 2013. PMID: 23555751 Free PMC article.

2

¹⁸F-FDG PET/CT for monitoring anti-PD-1 therapy in patients with non-small cell lung cancer using SUV harmonization of results obtained with various types of PET/CT scanners used at different centers.

Ito K, Kitajima K, Toriihara A, Ishibashi M, Nakahara T, Daisaki H, Ohe Y, Honda R, Kijima T, Hasegawa S, Nakajo M. Ito K, et al. Among authors: toriihara a. Ann Nucl Med. 2021 Nov;35(11):1253-1263. doi: 10.1007/s12149-021-01667-8. Epub 2021 Aug 9. Ann Nucl Med. 2021. PMID: 34370219

3

Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography combined with ultrasonography-guided fine needle aspiration cytology for identifying axillary lymph node status in patients with breast cancer.

Machida Y, Kubota K, Katayama T, Toriihara A, Shibuya H. Machida Y, et al. Among authors: toriihara a. Eur J Surg Oncol. 2013 Jan;39(1):26-30. doi: 10.1016/j.ejso.2012.10.012. Epub 2012 Nov 2. Eur J Surg Oncol. 2013. PMID: 23122913

4

Optimal timing of post-treatment [18F]fluorodeoxyglucose-PET/CT for patients with head and neck malignancy.

Nakamura S, Toriihara A, Okochi K, Watanabe H, Shibuya H, Kurabayashi T. Nakamura S, et al. Among authors: toriihara a. Nucl Med Commun. 2013 Feb;34(2):162-7. doi: 10.1097/MNM.0b013e32835bdfe3. Nucl Med Commun. 2013. PMID: 23196675

5

Clinical usefulness of 2-deoxy-2-[18F] fluoro-d-glucose-positron emission tomography/computed tomography for assessing early oral squamous cell carcinoma (cT1-2N0M0).

Yamaga E, Toriihara A, Nakamura S, Asai S, Fujioka T, Yoshimura R, Michi Y, Harada H, Tateishi U. Yamaga E, et al. Among authors: toriihara a. Jpn J Clin Oncol. 2018 Jul 1;48(7):633-639. doi: 10.1093/jjco/hyy065. Jpn J Clin Oncol. 2018. PMID: 29718274

6

Prevalence of esophageal cancer during the pretreatment of hypopharyngeal cancer patients: routinely performed esophagogastroduodenoscopy and FDG-PET/CT findings.

Nakaminato S, Toriihara A, Makino T, Kawano T, Kishimoto S, Shibuya H. Nakaminato S, et al. Among authors: toriihara a. Acta Oncol. 2012 May;51(5):645-52. doi: 10.3109/0284186X.2011.652260. Epub 2012 Jan 10. Acta Oncol. 2012. PMID: 22229748

7

Prognostic value of metabolic tumor burden calculated using dual-time-point 18F-fluorodeoxyglucose positron emission tomography/CT in patients with oropharyngeal or hypopharyngeal cancer.

Kuwabara H, Toriihara A, Yuasa-Nakagawa K, Toda K, Tateishi U, Yoshimura R. Kuwabara H, et al. Among authors: toriihara a. Head Neck. 2019 Jan;41(1):103-109. doi: 10.1002/hed.25490. Epub 2018 Dec 10. Head Neck. 2019. PMID: 30537436

8

Evaluation of sequential FDG-PET/CT for monitoring bone metastasis of breast cancer during therapy: correlation between morphological and metabolic changes with tumor markers.

Katayama T, Kubota K, Machida Y, Toriihara A, Shibuya H. Katayama T, et al. Among authors: toriihara a. Ann Nucl Med. 2012 Jun;26(5):426-35. doi: 10.1007/s12149-012-0595-2. Epub 2012 Apr 3. Ann Nucl Med. 2012. PMID: 22477261

9

Prognostic implications of ⁶²Cu-diacetyl-bis (N⁴-methylthiosemicarbazone) PET/CT in patients with glioma.

Toriihara A, Ohtake M, Tateishi K, Hino-Shishikura A, Yoneyama T, Kitazume Y, Inoue T, Kawahara N, Tateishi U. Toriihara A, et al. Ann Nucl Med. 2018 May;32(4):264-271. doi: 10.1007/s12149-018-1241-4. Epub 2018 Feb 16. Ann Nucl Med. 2018. PMID: 29453680 Clinical Trial.

10

Applying standardized uptake values in gallium-67-citrate single-photon emission computed tomography/computed tomography studies and their correlation with blood test results in representative organs.

Toriihara A, Daisaki H, Yamaguchi A, Yoshida K, Isogai J, Tateishi U. Toriihara A, et al. Nucl Med Commun. 2018 Aug;39(8):720-724. doi: 10.1097/MNM.0000000000000868. Nucl Med Commun. 2018. PMID: 29787517

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters